Elekta has been a leader in precision radiation medicine for almost five decades.
STOCKHOLM, Feb. 15, 2021 Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the third quarter 2020/21 at 10:00 a.m. CET on February 25. The interim report for the third quarter will be published at 7:30 a.m. CET on the same day.
The company’s development will be presented by Elekta’s President and CEO Gustaf Salford together with acting CFO Johan Adebäck. After the presentation, held in English, a Q&A session will follow.
The presentation will be broadcasted live on the web. It will be necessary to join the phone conference if you plan to ask questions. A recording of the webcast can be found on Elekta’s website after the call.
Time: Thursday, February 25, at 10:00 a.m. CET
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Elekta is a Swedish company that provides radiation therapy, radiosurgery, related equipment and clinical management for the treatment of cancer and brain disorders.
Elekta was jointly founded in 1972 by the late Lars Leksell, Professor of Neurosurgery at the Karolinska Institute in Stockholm, Sweden and his son Laurent Leksell, in order to commercialize the development of the Leksell Stereotactic System, and Gamma Knife, which he had been researching since the late 1940s.
Since 1994, the company has been listed on the Nordic Exchange under the ticker EKTAb. Lars Leksell’s son, Laurent, became chief executive officer of Elekta until 2005, and under his leadership the company expanded into a public medical technology group with more than 3,400 employees worldwide. In 2005 Tomas Puusepp became President and CEO of the company. The company trades only in Sweden, but nearly half the sales of the company’s equipment are in the United States. The company saw net sales of 10,839 SEK M (€1.16B as of January 2016) in the year 2014/15.